Elharam Ibrahim Abdallah

Elharam Ibrahim Abdallah

Auto-generated profile, based on publicly available information

Elharam Ibrahim Abdallah

Assistant Professor, Department of Hematology and Blood Transfusion, Faculty of Medical Laboratory Sciences, Alzaeim Alazhari University, Khartoum, Sudan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2020 in Research Square
Verified
Preprint
Open access
PDF file
EAElharam Ibrahim Abdallah
Elharam Ibrahim Abdallah
NMNazic Ibrahim M.Alamin
Nazic Ibrahim M.Alamin
WEWala Eldin Osman Elradi
Wala Eldin Osman Elradi
SESalah Eldin G. Elzaki
Salah Eldin G. Elzaki
NSNassrEldin Mohamed Ahmed Shrif
NassrEldin Mohamed Ahmed Shrif
Introduction: Interaction of environmental and genetic elements plays a vital role in the pathogenesis of CML and other types of cancer. CYP 3A5 is enzyme responsible of metabolizing of approximately 50 % of therapeutic drugs and xenobiotics. So polymorphism variation may genetically predispose individuals to CML.Objective: The purpose of this study was to determine CYP3A5*3 Polymorphism among Sudanese patients with Chronic Myeloid Leukemia (CML).Materials and Methods: This case control study was conducted among 50 patients with chronic myeloid leukemia among both genders at different ages and 42 apparently healthy control subjects. The CYP3A5*3 genotype was determined using (PCR-RFLP) method.Results: Paerson`s chi-square test was used to assess the possible link between CYP3A5*3 genotype and CML. The percentage of CYP3A5*3*3 genotype in CML patients was significantly higher than in control (OR = 11.71, 95% CI: 4.30 –31.83; p =0.000). The frequency of mutant genotype was higher among CML patients with advance phase compared with chronic phase, 100% versus 80% respectively.Conclusion: CYP3A5*3/*3 genotype associated with CML development and progression.

30 June 2020 in Research Square
Verified
Preprint
Open access
PDF file
TFToga Abdalazim Fadlalla
Toga Abdalazim Fadlalla
NYNusiba Abdullah Yousif
Nusiba Abdullah Yousif
RORayan Hamid Omer
Rayan Hamid Omer
MEMohamed Mobarak Elbasheir
Mohamed Mobarak Elbasheir
WEWalaEldin Osman Elradi
WalaEldin Osman Elradi
EAElharam Ibrahim Abdallah
Elharam Ibrahim Abdallah
Background: Traditional medicine had been used alongside synthetic pharmaceutical products to enhance health management. Due to the high mortality rate of sickle cell patients, previous studies have been indicated that some medicinal plants have shown an anti-sickling activity, which indicates a new therapeutic way to manage people who are affected by these disorders. The current study aimed to assess in vitro-anti-sickling activity of Hyphaene thebaica (H thebaica) (Doum) fruit. Materials and methods: Blood samples used in the evaluation of the anti-sickling activity of Hyphaene Thebaica Fruits extract in this study was taken from patients known to had Sickle cell disease (HB -SS ) attending the Sickle Cell Clinic in Khartoum state. Emmel test was used to assess anti-sickling activity of this plant. Result: A significant increase in the percentage of unsickled Red blood cells with p-value 0.05 >was observed after incubation of RBCs with 2% sodium metabisulfite in the presence of three different concentration (1000, 500 and 250) μg/ml of Hyphened thebaica for two type of extraction (aqueous and methanol) extract. Conclusion: This study approved that H.thebaica (Doum ) fruit extract had a strong anti- sickling activity ; it could be used for management of sickle cell disease.

1 January 2022 in Archives Of Pharmacy Practice
Verified
Journal Article
Open access
RMRofida Galal Eldein Mohamed
Rofida Galal Eldein Mohamed
EAElharam Ibrahim Abdallah
Elharam Ibrahim Abdallah
AMAbdel Rahim Mahmoud Muddathir
Abdel Rahim Mahmoud Muddathir
GAGhfren S. Aloraini
Ghfren S. Aloraini
AOAlaa Eltayeb Omer
Alaa Eltayeb Omer
LELienda Bashier Eltayeb
Lienda Bashier Eltayeb
SARS-CoV-2 is a systemic infection that has a significant impact on the hemostasis and hematopoietic system. Lymphopenia may be considered a cardinal laboratory finding, with prognostic potential. The study aimed to determine the differential leukocyte count in SARS-CoV-2 among Sudanese patients, during the period from March to December 2020. A total of 787 subjects were enrolled 487 patients with COVID-19 and 300 healthy volunteers as a control group; their ages ranged from 29 to 89 years. 3 ml